Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 18Recruiting 7Unknown 5Terminated 5Not yet recruiting 3Withdrawn 2Active not recruiting 2

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Pseudomyxoma Peritonei 1Peripheral Nervous System Diseases 1Ototoxicity 1Hearing Loss, Sensorineural 1Hearing Loss 1Head and Neck Neoplasms 1Ear Diseases 1Deafness 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × OTHER × Acetylcysteine × Clear all
NCT06297369 2024-03-07

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Ain Shams University

Phase 2 Unknown
60 enrolled

Ototoxicity, Peripheral Nervous System Diseases

NCT06039280 2023-09-15

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

Institute of Liver and Biliary Sciences, India

Phase NA Unknown
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Sunnybrook Health Sciences Centre

Phase 1/2 Unknown
80 enrolled

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss

NCT04982146 2022-06-02

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Maimónides Biomedical Research Institute of Córdoba

Phase 1 Unknown
10 enrolled

Pseudomyxoma Peritonei

NCT02241876 2014-09-16

THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS

University of Campinas, Brazil

Phase 4 Unknown
60 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡